We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$809M
AUM Growth
+$404M
Cap. Flow
+$13B
Cap. Flow %
1,601.81%
Top 10 Hldgs %
38.43%
Holding
159
New
60
Increased
32
Reduced
34
Closed
31

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$12.6B
2
AGN
Allergan plc
AGN
+$27.3M
3
ABBV icon
AbbVie
ABBV
+$22.4M
4
SHPG
Shire pic
SHPG
+$19.6M
5
PFE icon
Pfizer
PFE
+$18.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$12.7M
2
GSK icon
GSK
GSK
+$9.95M
3
BIIB icon
Biogen
BIIB
+$6.94M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$5.6M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 57.07%
2 Technology 4.45%
3 Energy 3.1%
4 Industrials 2.68%
5 Materials 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPRX
76
DELISTED
Catalyst Pharmaceutical
CPRX
$2.28M 0.28%
+685,500
New +$1.79M
VNDA icon
77
Vanda Pharmaceuticals
VNDA
$307M
$2.27M 0.28%
218,390
+78,390
+56% +$1.03M
MGNX icon
78
MacroGenics
MGNX
$235M
$2.25M 0.28%
107,781
-3,219
-3% -$66.6K
LJPC
79
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.15M 0.27%
+223,330
New +$2.22M
TRVN
80
DELISTED
Trevena, Inc.
TRVN
$2.13M 0.26%
530
-16
-3% -$60.4K
ARNA
81
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.1M 0.26%
+50,000
New +$2.23M
RLYP
82
DELISTED
RELYPSA INC COM
RLYP
$2.05M 0.25%
+97,100
New +$2.35M
AKBA icon
83
Akebia Therapeutics
AKBA
$354M
$1.99M 0.25%
89,817
+17,317
+24% +$398K
IMMU
84
DELISTED
Immunomedics Inc
IMMU
$1.99M 0.25%
534,050
-15,950
-3% -$53.9K
ATNM icon
85
Actinium Pharmaceuticals
ATNM
$26.3M
$1.95M 0.24%
9,710
-290
-3% -$57.5K
SNA icon
86
Snap-on
SNA
$21.2B
$1.95M 0.24%
+16,100
New +$1.98M
EIGR
87
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.94M 0.24%
413
+80
+24% +$423K
KITE
88
DELISTED
Kite Pharma, Inc.
KITE
$1.94M 0.24%
+67,970
New +$1.68M
MA icon
89
Mastercard
MA
$502B
$1.92M 0.24%
+26,000
New +$1.98M
BLUE
90
DELISTED
bluebird bio
BLUE
$1.92M 0.24%
+4,123
New +$1.9M
LRMR icon
91
Larimar Therapeutics
LRMR
$397M
$1.91M 0.24%
+8,092
New +$1.83M
ALDR
92
DELISTED
Alder Biopharmaceuticals
ALDR
$1.9M 0.24%
+150,000
New +$2.27M
MRNS
93
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.9M 0.23%
+73,383
New +$2.27M
ELLO icon
94
Ellomay Capital Ltd
ELLO
$270M
$1.89M 0.23%
191,202
+170,638
+830% +$1.62M
RNA
95
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$1.85M 0.23%
219,345
+94,345
+75% +$894K
OMED
96
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.84M 0.23%
97,100
+22,100
+29% +$444K
MNKD icon
97
PUT
MannKind Corp
MNKD
$1.21B
$1.77M 0.22%
+60,000
New +$2.37M
TJX icon
98
TJX Companies
TJX
$174B
$1.63M 0.2%
55,200
+3,368
+6% +$95K
RXDX
99
DELISTED
Ignyta, Inc.
RXDX
$1.6M 0.2%
199,055
-5,945
-3% -$47.8K
TLPH icon
100
Talphera
TLPH
$66.4M
$1.59M 0.2%
+14,492
New +$2.28M
2 3
4
5 6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sphera Funds Management held 159 positions worth $809M, up 99% from $406M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $13B of net new capital in Q3 2014, opening 60 new positions and adding to 32 existing holdings. Its largest new stake was Isramco Inc: 103,111,944 shares worth $22.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 74% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was GSK, an estimated $9.95M trimmed.

  • Sphera Funds Management's largest Q3 2014 buy was Isramco Inc: 103,111,944 shares worth $22.1M.
  • Sphera Funds Management added most to Shire pic in Q3 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q3 2014 reduction was GSK, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Sanofi in Q3 2014, selling an estimated $12.7M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $809M portfolio in Q3 2014.
  • Sphera Funds Management opened 60 new positions and closed 31 in Q3 2014.
  • Sphera Funds Management's portfolio value rose 99% quarter-over-quarter to $809M.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.